Eric Zylstra, Ph.D., is an associate whose practice focuses on patent prosecution and counseling, including opinion writing, due diligence, and patent portfolio strategy, working primarily in the chemical and pharmaceutical sciences. His technology experience includes small molecules, pharmaceutical and agricultural formulations, dyes, and fuel cells. Before joining the firm as a student associate, he worked as a technical advisor, patent agent, and student associate at Townsend and Townsend and Crew.
Dr. Zylstra’s technical experience includes total synthesis of natural products, organic methodology, solid-and solution-phase parallel synthesis and polymer chemistry. He was a senior scientist at Discovery Partners International (previously known as ChemRx and Axys Advanced Technologies) where his area of research was synthetic and medicinal chemistry for early-stage drug discovery. He was also a postdoctoral research scientist for the Pharmaceutical Science Department at the University of Tokyo, where his area of research was total synthesis of natural products.
Represented Prometheus Laboratories, Inc. owner of an Orange Book listed branded drug, Lotronex (alosetron hydrochloride), indicated for women with severe Irritable Bowel Syndrome. Prometheus Labs bought the franchise from GSK several years ago, however US Patent No. 6,284,770 drawn to a method for treatment was not listed in the Orange Book. A reexamination strategy was devised to ensure patentability of the claims that covered the indication. After an initial PTO action denying the reexamination request, a petition was filed citing further relevant facts. Thereafter, the petition was granted. After successful prosecution of amended claims, a reexamination certificate issued providing valid patent coverage for Lotronex. The reexamined patent is now listed in the Orange Book.
University of San Francisco School of Law, J.D. magna cum laude, Certificate in Intellectual Property with Honors
University of California, Berkeley, Ph.D., Synthetic Chemistry
Massachusetts Institute of Technology, S.B. Double Major in Chemistry and Literature
U.S. Patent and Trademark Office (2007)
American Chemical Society, Member (1992-Present)
American Association of Intellectual Property Law, Member (2009-Present)
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.